Latest News and Updates

Stay informed about conveyxo’s progress in RNA-enhanced exosome, partnerships, scientific advancements, and company milestones.
‍
Explore our latest announcements, collaborations, and insights as we continue developing next-generation regenerative therapeutics.

December 11, 2025

convEyXO Strengthens Strategic Development in China with Signing Ceremony in Suzhou

October 2, 2025

Conveyxo has been selected for the prestigious Saudi Biotechnology Accelerator‘s Venture Readiness Program 2025!

October 1, 2025

New collaboration! conveyxo is teaming up with SATT Paris-Saclay to load their miRNA cargo into our exosomes and evaluate therapeutic impact against intestinal inflammation (IBD)

September 12, 2025

Was a honor to pitch at Beiersdorf Connect – invitation-only – alongside 4 other inspiring founders and a sharp jury!

September 1, 2025

We are thrilled to welcome Alexandre Lennaertz to the conveyxo team as our Operations Manager

August 16, 2025

Charles Jacques is appointed as Chief Finance Officer

convEyXO is thrilled to welcome Tamara Davenne, PhD, to the management team as Translational Science Leader

BIO Informant – EXO-Harvest, an affiliate of convEyXO, is thrilled to announce the successful launch of its cutting-edge multi-scale bioreactor platform for adherent cells and extracellular vesicles (EVs) production, in partnership with IPRATECH.

EXO-Harvest, an affiliate of convEyXO, is thrilled to announce the successful launch of its cutting-edge multi-scale bioreactor platform for adherent cells and extracellular vesicles (EVs) production, in partnership with IPRATECH.

convEyXO’s affiliate EXO-HARVEST collaborates with IPRATECH

convEyXO et SomesTech annoncent la création de la joint-venture XomeXBio pour développer le potentiel des exosomes ciblés en tant que système de délivrance de médicaments en médecine personnalisée

Conveyxo and SomesTech Announce XomeXBio Joint Venture to Unleash Full Potential of Targeted Exosomes as drug delivery system for precision medicine